Nitric oxide differentially regulates pro- and anti-angiogenic markers in DLD-1 colon carcinoma cells

FEBS Letters

Volumn 563, Issue 1-3, 2004, Pages 98-102

  Hellmuth, Markus ^a   Paulukat, Jens ^a   Ninic, Raiko ^a   Pfeilschifter, Josef ^a   Mühl, Heiko ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Angiogenesis; Chemokine; Colon carcinoma cell; GAPDH, glyceraldehyde 3 phosphate dehydrogenase; IFN , interferon ; IL, interleukin; IP 10, interferon inducible protein 10; MIG, monokine induced by interferon ; Nitric oxide

Indexed keywords

ANGIOGENESIS INHIBITOR; CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON DERIVATIVE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL STIMULATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BIOLOGICAL MARKERS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-8; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842788177     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(04)00275-3     Document Type: Article

References (36)

1. Pfeilschifter J. Nephrol. Dial. Transplant. 17:2002;347-348.
2. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., Harris C.C. Cancer Res. 58:1998;334-341.
3. Ambs S., Bennett W.P., Merriam W.G., Ogunfusika M.O., Oser S.M., Harrington A.M., Shields P.G., Felley-Bosco E., Hussain S.P., Harris C.C. J. Natl. Cancer Inst. 91:1999;86-88.
4. Szaleczky E., Pronai L., Nakazawa H., Tulassay Z. J. Clin. Gastroenterol. 30:2000;47-51.
5. Jenkins D.C., Charles I.G., Baylis S.A., Lelchuk R., Radomski M.W., Moncada S. Br. J. Cancer. 70:1994;847-849.
6. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., Moncada S. Proc. Natl. Acad. Sci. USA. 92:1995;4392-4396.
7. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., Strieter R.M. J. Leukoc. Biol. 68:2000;1-8.
8. Cross M.J., Claesson-Welsh L. Trends Pharmacol. Sci. 22:2001;201-207.
9. Hellmuth M., Wetzler C., Nold M., Chang J.H., Frank S., Pfeilschifter J., Mühl H. Carcinogenesis. 23:2002;1273-1279.
10. Frank S., Stallmeyer B., Kampfer H., Kolb N., Pfeilschifter J. FASEB J. 13:1999;2002-2014.
11. Kunz D., Mühl H., Walker G., Pfeilschifter J. Proc. Natl. Acad. Sci. USA. 91:1994;5387-5391.
12. Mühl H., Chang J.H., Huwiler A., Bosmann M., Paulukat J., Ninic R., Nold M., Hellmuth M., Pfeilschifter J. Free Radic. Biol. Med. 29:2000;969-980.
13. Keefer L.K. Annu. Rev. Pharmacol. Toxicol. 43:2003;585-607.
14. Okada F., Rak J.W., Croix B.S., Lieubeau B., Kaya M., Roncari L., Shirasawa S., Sasazuki T., Kerbel R.S. Proc. Natl. Acad. Sci. USA. 95:1998;3609-3614.
15. Csiszar A., Szentes T., Haraszti B., Zou W., Emilie D., Petranyi G., Pocsik E. Eur. Cytokine Netw. 12:2001;87-96.
16. Numata A., Minagawa T., Asano M., Natane A., Katoh H., Tanabe T. Cancer. 86:1991;1937-1943.
17. Yoshimi N., Sato S., Makita H., Wang A., Hirose Y., Tanaka T., Mori H. Carcinogenesis. 15:1994;783-785.
18. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Br. J. Cancer. 72:1995;41-44.
19. Gallo O., Masini E., Morbidelli L., Franchi A., Fini-Storchi I., Vergari W.A., Ziche M. J. Natl. Cancer Inst. 90:1998;587-596.
20. Buga G.M., Wei L.H., Bauer P.M., Fukuto J.M., Ignarro L.J. Am. J. Physiol. 275:1998;R1256-R1264.
21. Cui S., Reichner J.S., Mateo R.B., Albina J.E. Cancer Res. 54:1994;2462-2467.
22. Lagares-Garcia J.A., Moore R.A., Collier B., Heggere M., Diaz F., Qian F. Am. Surg. 67:2001;709-713.
23. Akbulut H., Altuntas F., Akbulut K.G., Ozturk G., Cindoruk M., Unal E., Icli F. Cytokine. 20:2002;184-190.
24. Holash J., Wiegand S.J., Yancopoulos G.D. Oncogene. 18:1999;5356-5362.
25. Beltran B., Orsi A., Clementi E., Moncada S. Br. J. Pharmacol. 129:2000;953-960.
26. Brown Z., Robson R.L., Westwick J. Adv. Exp. Med. Biol. 351:1993;65-75.
27. Villarete L.H., Remick D.G. Biochem. Biophys. Res. Commun. 211:1995;671-676.
28. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., Strieter R.M. Science. 258:1992;1798-1801.
29. Brew R., Erikson J.S., West D.C., Kinsella A.R., Slavin J., Christmas S.E. Cytokine. 12:2000;78-85.
30. Chin K., Kurashima Y., Ogura T., Tajiri H., Yoshida S., Esumi H. Oncogene. 15:1997;437-442.
31. Jozkowicz A., Cooke J.P., Guevara I., Huk I., Funovics P., Pachinger O., Weidinger F., Dulak J. Cardiovasc. Res. 51:2001;773-783.
32. Kisley L.R., Barrett B.S., Bauer A.K., Dwyer-Nield L.D., Barthel B., Meyer A.M., Thompson D.C., Malkinson A.M. Cancer Res. 62:2002;6850-6856.
33. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., Luster A.D. J. Clin. Invest. 104:1999;1041-1050.
34. Llovera M., Pearson J.D., Moreno C., Riveros-Moreno V. Br. J. Pharmacol. 132:2001;419-426.
35. Huwiler A., Pfeilschifter J. Biol. Chem. 384:2003;1379-1389.
36. Rao C.V., Kawamori T., Hamid R., Reddy B.S. Carcinogenesis. 20:1999;641-644.